AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 43.23%3.37M | -427.12%-579K | 205.88%342K | 41.86%3.2M | 67.07%411K | 4.25%2.36M | -80.11%177K | 56.93%-323K | -10.55%2.26M | 161.19%246K |
Net income from continuing operations | 146.58%952K | 30.15%-607K | 108.94%1.73M | 532.84%883K | 41.41%-1.05M | -108.57%-2.04M | 17.71%-869K | -22.76%828K | -150.50%-204K | -28.50%-1.8M |
Operating gains losses | ---7K | --0 | --0 | --0 | ---7K | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 2.09%3.91M | -1.96%949K | 1.25%975K | 4.92%1M | 4.26%980K | 9.85%3.83M | 4.09%968K | 9.18%963K | 13.42%955K | 13.39%940K |
Deferred tax | ---19K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cash items | 0.00%60K | -40.00%15K | 50.00%15K | 0.00%15K | 50.00%15K | 20.00%60K | 66.67%25K | -28.57%10K | 50.00%15K | -9.09%10K |
Change In working capital | -447.15%-1.58M | -4,454.55%-958K | -11.55%-2.39M | -12.82%1.29M | -57.01%469K | 238.18%456K | -97.75%22K | 21.48%-2.14M | 17.62%1.48M | 603.87%1.09M |
-Change in receivables | -48.57%825K | -29.71%1.63M | 766.29%1.78M | -79.38%413K | -22.28%-3M | 228.63%1.6M | -8.70%2.32M | 90.09%-267K | 1,989.62%2M | -148.08%-2.45M |
-Change in inventory | 151.74%104K | 187.04%155K | 42.11%162K | 85.86%-14K | 26.30%-199K | 43.54%-201K | 92.86%54K | 178.05%114K | 42.44%-99K | -6.72%-270K |
-Change in prepaid assets | 101.79%113K | -92.26%-323K | 105.10%201K | -2.20%401K | 41.55%-166K | 131.82%56K | -47.37%-168K | 182.35%98K | 70.12%410K | -54.35%-284K |
-Change in payables and accrued expense | -147.40%-2.91M | -24.80%-1.4M | -311.20%-3.23M | 78.55%-354K | -12.76%2.08M | -232.02%-1.18M | -202.97%-1.12M | -192.58%-786K | -380.14%-1.65M | 1,438.20%2.38M |
-Change in other current assets | -97.80%2K | 150.00%1K | 0.00%2K | -104.17%-1K | --0 | --91K | 86.67%-2K | -50.00%2K | 147.06%24K | 8.06%67K |
-Change in other current liabilities | -29.18%199K | 8.70%125K | 41.44%-106K | 430.23%142K | -90.26%38K | 0.72%281K | 236.90%115K | -155.35%-181K | 46.25%-43K | 236.21%390K |
-Change in other working capital | 140.50%81K | 2.38%-1.15M | -6.52%-1.19M | -15.77%705K | 36.44%1.72M | -171.43%-200K | -16.80%-1.18M | 1.24%-1.12M | -0.24%837K | -20.44%1.26M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 43.23%3.37M | -427.12%-579K | 205.88%342K | 41.86%3.2M | 67.07%411K | 4.25%2.36M | -80.11%177K | 56.93%-323K | -10.55%2.26M | 161.19%246K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 42.37%-2.25M | 20.12%-548K | -0.10%-1M | 68.71%-348K | 68.31%-348K | 39.04%-3.9M | 40.91%-686K | 48.08%-1M | 44.95%-1.11M | 14.49%-1.1M |
Capital expenditure reported | 42.19%-2.25M | 20.12%-548K | -0.10%-1M | 68.71%-348K | 67.67%-355K | 39.04%-3.9M | 40.91%-686K | 48.08%-1M | 44.95%-1.11M | 14.49%-1.1M |
Net PPE purchase and sale | --7K | --0 | --0 | --0 | --7K | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 42.37%-2.25M | 20.12%-548K | -0.10%-1M | 68.71%-348K | 68.31%-348K | 39.04%-3.9M | 40.91%-686K | 48.08%-1M | 44.95%-1.11M | 14.49%-1.1M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -186.65%-818K | -124.09%-199K | -17.31%-244K | -16.85%-215K | -131.37%-160K | -91.60%944K | 92.09%826K | -101.84%-208K | 45.88%-184K | 422.78%510K |
Net issuance payments of debt | -186.65%-818K | -124.09%-199K | -17.31%-244K | -16.85%-215K | -131.37%-160K | -91.70%944K | 92.09%826K | -101.80%-208K | 45.88%-184K | 270.00%510K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -186.65%-818K | -124.09%-199K | -17.31%-244K | -16.85%-215K | -131.37%-160K | -91.60%944K | 92.09%826K | -101.84%-208K | 45.88%-184K | 422.78%510K |
Net cash flow | ||||||||||
Beginning cash position | -4.96%11.45M | 17.53%13.09M | 10.45%13.99M | -3.02%11.36M | -4.96%11.45M | 143.43%12.05M | -6.36%11.14M | 287.73%12.67M | 276.95%11.71M | 143.43%12.05M |
Current changes in cash | 151.67%309K | -518.30%-1.33M | 40.99%-904K | 174.87%2.64M | 71.64%-97K | -108.42%-598K | 99.37%317K | -117.76%-1.53M | 495.65%959K | 81.45%-342K |
End cash Position | 2.70%11.76M | 2.70%11.76M | 17.53%13.09M | 10.45%13.99M | -3.02%11.36M | -4.96%11.45M | -4.96%11.45M | -6.36%11.14M | 287.73%12.67M | 276.95%11.71M |
Free cash flow | 172.63%1.12M | -121.41%-1.13M | 50.15%-660K | 149.43%2.85M | 106.57%56K | 62.70%-1.54M | -87.82%-509K | 50.56%-1.32M | 128.14%1.14M | 49.47%-852K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |